• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Autistic Disorder Pipeline: Emerging Therapies and Key Pharma Players Involved By Delveinsight

Share:

May 26, 2021

Autistic Disorder is a broad term used to describe a group of neurodevelopmental disorders. These disorders are characterized by problems with communication and social interaction. People with ASD often demonstrate restricted, repetitive, and stereotyped interests or patterns of behavior.

DelveInsight’s, ” Insight, 2021,” report provides comprehensive insights into 20+ companies and 30+ pipeline drugs in the Autistic Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Some the Autistic Disorder Companies are:

  • Caremark
  • GW Pharmaceuticals
  • Zynerba Pharmaceuticals
  • BrainStorm Cell Therapeutics
  • Jaguar Gene Therapy
  • Confluence Pharmaceuticals
  • Finch Therapeutics
  • AbbVie
  • And Many Others

Read more here

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Menafn

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Report Finds Half of Older Patients Prefer Digital Tools to In-Person ConsultationsReport Finds Half of Older Patients Prefer Digital Tools to In-Person Consultations
  • Improving health outcomes by tackling health literacy: NHS Scotland focusImproving health outcomes by tackling health literacy: NHS Scotland focus
  • Brainlab Acquires Medical Video Game Innovator Level ExBrainlab Acquires Medical Video Game Innovator Level Ex
  • Vatica Health Acquires CareSync’s Technology to Expand Value-Based Care CapabilitiesVatica Health Acquires CareSync’s Technology to Expand Value-Based Care Capabilities
  • Dexcom Beats Revenue Expectations By $46.7M; Peloton Sees 66% YoY Growth, and This Week’s Other Digital Health Earnings TakeawaysDexcom Beats Revenue Expectations By $46.7M; Peloton Sees 66% YoY Growth, and This Week’s Other Digital Health Earnings Takeaways
  • National Kidney Foundation and the American Society of Nephrology Release New Way to Diagnose Kidney DiseasesNational Kidney Foundation and the American Society of Nephrology Release New Way to Diagnose Kidney Diseases
  • COVID-19 Underscores Why Certain Aspects of the American Healthcare System Should Change ForeverCOVID-19 Underscores Why Certain Aspects of the American Healthcare System Should Change Forever
  • Abbott to Launch App to Track and Report Pain Relief in Chronic Pain PatientsAbbott to Launch App to Track and Report Pain Relief in Chronic Pain Patients

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications